Perinatal management of a preterm neonate affected by hyperprostaglandin E2 syndrome (HPS)

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 11, 2005, Pages 1690-1693

  Kömhoff, Martin ^a   Tekesin, Ismail ^a   Peters, Melanie ^a   Leonhard, Andreas ^a   Seyberth, Hannsjörg ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Bartter syndrome; Cyclooxygenase 2; Macula densa; Neonatal renal failure

Indexed keywords

INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM CHLORIDE; WATER;

ACUTE KIDNEY FAILURE; ARTICLE; BARTTER SYNDROME; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HYPERPROSTAGLANDIN E2 SYNDROME; KIDNEY FUNCTION; NATRIURESIS; POLYURIA; PREMATURITY; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; REDUCTION; SALT LOSING NEPHRITIS; SODIUM URINE LEVEL; URINARY EXCRETION; WATER LOSS;

BARTTER SYNDROME; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; KIDNEY FAILURE; PERINATAL CARE;

EID: 28744452520     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250510043897     Document Type: Article

References (16)

1. Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002;112:183-90.
2. Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 1985;107: 694-701.
3. Jeck N, Schlingmann KP, Reinalter SC, Kömhoff M, Peters M, Waldegger S, et al. Salt handling in the distal nephron: Lessons learned from Inherited Human Disorders. Am J Physiol. 2005; 288:R782-95.
4. Kömhoff M, Reinalter SC, Gröne HJ, Seyberth HW. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatric Res 2004;55:in press.
5. Kramer BK, Kammerl MC, Komhoff M. Renal cyclooxygenase-2 (Cox-2). Physiological, pathophysiological, and clinical implications. Kidney Blood Press Res 2004;27:43-62.
6. Drukker A, Mosig D, Guignard JP. The renal hemodynamic effects of Aspirin in newborn and young adult rabbits. Pediatr Nephrol 2001;16:713-8.
7. Proesmans W. How can one apply rescue indomethacin therapy to a 1-month-old baby with antenatal Bartter syndrome in the case of severe vomiting? Pediatr Nephrol 2001;16:532.
8. Vargas-Poussou R, Feldmann D, Vollmer M, Konrad M, Kelly L, van den Heuvel LP, et al. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet 1998;62: 1332-40.
9. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nusing RM, Seyberth HW, et al. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2002;62:253-60.
10. Leonhardt A, Busch C, Schweer H, Seyberth HW. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. Acta Paediatr 1992;81:191-6.
11. Proesmans W. Bartter syndrome and its neonatal variant. Eur J Pediatr.1997;156:669-79.
12. Konrad M, Leonhardt A, Hensen P, Seyberth HW, Köckerling A. Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics 1999;103:678-83.
13. Breyer MD, Harris RC. Cyclooxygenase 2 and the kidney. Curr Opin Nephrol Hypertens. 2001;10:89-98.
14. Zhang MZ, Wang JL, Cheng HF, Harris RC, McKanna JA. Cyclooxygenase-2 in rat nephron development. Am J Physiol. 1997;273:F994-1002.
15. Breyer MD, Breyer RM. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol. 2000;279:F12-23.
16. Vanhaesebrouck S, Allegaert K, Vanhole C, Devlieger H, Gewillig M, Proesmans W. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion. Eur J Pediatr. 2003;162:569-71.